Seohung Healthcare, "Achieves Flawless Grade in FDA On-Site Inspection"

Seohung Healthcare announced on the 28th that it received a "No negative finding" rating in the on-site inspection of its Ochang factory in Chungbuk by the U.S. Food and Drug Administration (FDA). This on-site inspection was conducted by an overseas manufacturer inspection expert from the FDA headquarters in the United States.

Seohung Healthcare Logo
Photo by Seohung Healthcare

The inspection took place over five days last month due to the increasing export volume of liquid dietary supplements manufactured by Seohung Healthcare to the United States. Successfully passing the FDA inspection for the first time since its establishment, the company explained that it has once again proven its competitiveness as a global original equipment manufacturer (OEM) and original design manufacturer (ODM) capable of stably producing and supplying health functional foods both domestically and internationally. In particular, the inspection targeted Seohung Healthcare’s main production item, liquid low-acid dietary supplements, a formulation known for its demanding quality control, with the U.S. FDA requiring high standards of quality management and testing items.

Park Geum-deok, CEO of Seohung Healthcare, said, “We are pleased to have passed the U.S. FDA on-site inspection with no negative findings, based on Seohung Healthcare’s long-standing efforts and expertise,” adding, “We will continue to strengthen quality control and regulatory monitoring to support the active exports of our partners.”

This content was produced with the assistance of AI translation services.